mCRPC: Enzalutamid ist Bicalutamid überlegen
Crossref DOI link: https://doi.org/10.1007/s00092-017-1424-7
Published Online: 2017-03-04
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Walter, Monika
